3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. (Q52579869)

3 May 2018

title

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. (English)

1 reference

3 May 2018

author name string

I Lamensdorf

1

1 reference

3 May 2018

G Eisenhofer

2

1 reference

3 May 2018

J Harvey-White

3

1 reference

3 May 2018

A Nechustan

4

1 reference

3 May 2018

K Kirk

5

1 reference

3 May 2018

I J Kopin

6

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

3 May 2018

published in

Brain Research

1 reference

3 May 2018

volume

868

1 reference

3 May 2018

page(s)

191-201

1 reference

3 May 2018

issue

2

1 reference

3 May 2018

1-Methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Kir6.2 oligoantisense administered into the globus pallidus reduces apomorphine-induced turning in 6-OHDA hemiparkinsonian rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

The protective effect of the olive oil polyphenol (3,4-dihydroxyphenyl)-ethanol counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

An endogenous dopaminergic neurotoxin: implication for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Toxicity of Dopamine to Striatal Neurons In Vitro and Potentiation of Cell Death by a Mitochondrial Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Mitochondrial dysfunction in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Etiology and pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Metabolic inhibition increases glutamate susceptibility on a PC12 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Human complex I defects in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902309-X

10.1016/S0006-8993(00)02309-X

7 January 2021

Identifiers

DOI

1 reference

3 May 2018

release_ida2buolhja6xbfoldinfochie

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ida2buolhja6xbfoldinfochie

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10854571

1 reference

3 May 2018